Current Trials

CM0120 Cardiovascular

 CMAX 18a North Terrace, Adelaide

In this trial we are looking to evaluate the safety and tolerability of the Study Drug in patients with Elevated Plasma Lipoprotein (a).

This could potentially be a treatment for adults with atherosclerotic cardiovascular disease to reduce the risk of cardiovascular events.

Eligibility requirements

  • Age: 18-65
  • Sex: Male and females
  • BMI: 18-32 inclusive
  • Medication: Stable Statin use for at least 6 weeks prior to study
  • Medical History: Elevated Lipoprotein(a) (> 200nmol/L) Please note that this will be tested at the screening appointment to confirm
  • Smoking History: Non-smoker

Outpatient Visits

  • 17 visits over 365 days

Payment/Renumeration

  • TBD

How to apply

To register your interest in this trial, please complete this form. A Fusion team member will be in contact to discuss your eligibility shortly.